Join us on May 14 at 1:00 p.m. as we discuss
Bad Blood: Secrets and Lies in a Silicon Valley Startup by John Carreyrou. In 2014, Elizabeth Holmes, Theranos founder and CEO, was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one problem: The technology didn’t work.
For more information, please call the Reader Services Department at 516-794-2570 ext. 236.
No comments:
Post a Comment